Literature DB >> 18815547

Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography.

Niccolo' Faccioli1, Mirko D'Onofrio, Roberto Malagò, Giulia Zamboni, Massimo Falconi, Paola Capelli, Roberto Pozzi Mucelli.   

Abstract

UNLABELLED: To evaluate if contrast-enhanced ultrasonography (CEUS) improves the depiction of tumoral margins of pancreatic adenocarcinoma in relation to tumor enhancement, using pathology as criterion standard.
METHODS: Two hundred forty-one patients affected by pancreatic ductal adenocarcinoma were investigated at CEUS with a second-generation contrast medium of sulfur-hexafluoride microbubbles. Sixty-seven (27.8%) of 241 tumors were resected. By consensus, 2 radiologists reviewed the CEUS examination results of the 67 tumors judging the enhancement as low (hypovascular lesions, hypoechoic tothe adjacent parenchyma) or high (iso- or hypervascular lesions, iso- or hyperechoic to the adjacent parenchyma). The resected tumors were evaluated at pathology for the presence of positive neoplastic (R+) or negative neoplastic (R-) resected margins.
RESULTS: Of the 67 resected tumors, 35 (52.3%) were R-, whereas 32 (47.7%) were R+. Moreover, at CEUS, of the 67 resected tumors, 43 (64.1%) were hypovascular with low enhancement and 24 (35.8%) were iso-hypervascular with high enhancement. In the R- group, 27 (77.1%) of 35 tumors were hypovascular. In the R+ group, 16 (50%) of 32 lesions were hypovascular.
CONCLUSIONS: At CEUS the depiction of tumoral margins of pancreatic adenocarcinoma is more accurate in low enhancement than in high enhancement. The pattern of enhancement of pancreatic adenocarcinoma influences the depiction of tumoral margins at CEUS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815547     DOI: 10.1097/MPA.0b013e31816c908b

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  5 in total

Review 1.  Efficacy of Contrast-Enhanced Endoscopic Ultrasonography for the Diagnosis of Pancreatic Tumors.

Authors:  Kensuke Yokoyama; Atsushi Kanno; Tetsurou Miwata; Hiroki Nagai; Eriko Ikeda; Kozue Ando; Yuki Kawasaki; Kiichi Tamada; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Diagnostics (Basel)       Date:  2022-05-25

2.  A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography.

Authors:  Junko Fukuda; Sachiko Tanaka; Nobuko Ishida; Tatsuya Ioka; Kenji Ikezawa; Rena Takakura; Miho Nakao; Kazuyoshi Ohkawa; Kazuhiro Katayama; Shigenori Nagata
Journal:  J Med Ultrason (2001)       Date:  2018-02-22       Impact factor: 1.314

Review 3.  Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.

Authors:  Henricus J M Handgraaf; Martin C Boonstra; Arian R Van Erkel; Bert A Bonsing; Hein Putter; Cornelis J H Van De Velde; Alexander L Vahrmeijer; J Sven D Mieog
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 4.  The Diagnosis of Autoimmune Pancreatitis Using Endoscopic Ultrasonography.

Authors:  Atsushi Kanno; Eriko Ikeda; Kozue Ando; Hiroki Nagai; Tetsuro Miwata; Yuki Kawasaki; Yamato Tada; Kensuke Yokoyama; Norikatsu Numao; Jun Ushio; Kiichi Tamada; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Diagnostics (Basel)       Date:  2020-11-25

Review 5.  Contrast-enhanced endoscopic ultrasound.

Authors:  Christoph F Dietrich; M Sharma; M Hocke
Journal:  Endosc Ultrasound       Date:  2012-10       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.